Cargando…

The Clinical Burden of Clostridioides difficile in Ontario, Canada

BACKGROUND: To understand the clinical burden of Clostridioides difficile infection (CDI), we analyzed health outcome data from Ontario, Canada for CDI associated with and manifested in acute care hospitals (ACH), long-term care facilities (LTCF), the community, or ACH-associated with community-onse...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Jennifer A, McGeer, Allison, Tomovici, Antigona, Selmani, Alex, Chit, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993863/
https://www.ncbi.nlm.nih.gov/pubmed/32025524
http://dx.doi.org/10.1093/ofid/ofz523
_version_ 1783493116903292928
author Pereira, Jennifer A
McGeer, Allison
Tomovici, Antigona
Selmani, Alex
Chit, Ayman
author_facet Pereira, Jennifer A
McGeer, Allison
Tomovici, Antigona
Selmani, Alex
Chit, Ayman
author_sort Pereira, Jennifer A
collection PubMed
description BACKGROUND: To understand the clinical burden of Clostridioides difficile infection (CDI), we analyzed health outcome data from Ontario, Canada for CDI associated with and manifested in acute care hospitals (ACH), long-term care facilities (LTCF), the community, or ACH-associated with community-onset. METHODS: We performed a retrospective analysis using individual-level data from Ontario databases (April 1, 2005 to March 31, 2015), identifying CDI cases ≥18 years requiring hospitalization, and stratifying into cohorts based on association and onset location. Cohort members were matched to controls on demographics and medical conditions at onset, for outcomes including 30- and 180-day all-cause mortality and rehospitalization. RESULTS: We stratified 22 617 individuals hospitalized with CDI during the study period: 13 152 (58.1%) ACH-associated/ACH-onset, 7116 (31.5%) community-associated/community-onset, 1847 (8.2%) ACH-associated/community-onset, and 502 (2.2%) LTCF-associated/LTCF-onset. Compared with controls, unadjusted 30-day rehospitalization rates were significantly higher (P < .0001) for ACH-associated/ACH-onset CDI (9.5% vs 0.4%), LTCF-associated/LTCF-onset (7.2% vs 1.1%), community-associated/community-onset (7.8% vs 0.8%), and ACH-associated/community-onset (10.9% vs 0.7%). One hundred eighty-day mortality rates were higher in the community-associated/community-onset and the LTCF-associated/LTCF-onset cohorts than controls: 66.3% vs 12.3% (P < .0001) and 30.9% vs 3.1% (P < .0001), respectively. All differences remained significant after adjusting for patient factors. CONCLUSIONS: Clostridioides difficile infection is associated with higher rates of 30-day rehospitalization compared with controls. In addition, mortality rates within 180-days of hospital discharge are significantly higher for community-associated/community-onset and LTCF-associated/LTCF-onset CDI cohorts than controls. Clostridioides difficile infection warrants increased prevention and monitoring efforts.
format Online
Article
Text
id pubmed-6993863
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-69938632020-02-05 The Clinical Burden of Clostridioides difficile in Ontario, Canada Pereira, Jennifer A McGeer, Allison Tomovici, Antigona Selmani, Alex Chit, Ayman Open Forum Infect Dis Major Article BACKGROUND: To understand the clinical burden of Clostridioides difficile infection (CDI), we analyzed health outcome data from Ontario, Canada for CDI associated with and manifested in acute care hospitals (ACH), long-term care facilities (LTCF), the community, or ACH-associated with community-onset. METHODS: We performed a retrospective analysis using individual-level data from Ontario databases (April 1, 2005 to March 31, 2015), identifying CDI cases ≥18 years requiring hospitalization, and stratifying into cohorts based on association and onset location. Cohort members were matched to controls on demographics and medical conditions at onset, for outcomes including 30- and 180-day all-cause mortality and rehospitalization. RESULTS: We stratified 22 617 individuals hospitalized with CDI during the study period: 13 152 (58.1%) ACH-associated/ACH-onset, 7116 (31.5%) community-associated/community-onset, 1847 (8.2%) ACH-associated/community-onset, and 502 (2.2%) LTCF-associated/LTCF-onset. Compared with controls, unadjusted 30-day rehospitalization rates were significantly higher (P < .0001) for ACH-associated/ACH-onset CDI (9.5% vs 0.4%), LTCF-associated/LTCF-onset (7.2% vs 1.1%), community-associated/community-onset (7.8% vs 0.8%), and ACH-associated/community-onset (10.9% vs 0.7%). One hundred eighty-day mortality rates were higher in the community-associated/community-onset and the LTCF-associated/LTCF-onset cohorts than controls: 66.3% vs 12.3% (P < .0001) and 30.9% vs 3.1% (P < .0001), respectively. All differences remained significant after adjusting for patient factors. CONCLUSIONS: Clostridioides difficile infection is associated with higher rates of 30-day rehospitalization compared with controls. In addition, mortality rates within 180-days of hospital discharge are significantly higher for community-associated/community-onset and LTCF-associated/LTCF-onset CDI cohorts than controls. Clostridioides difficile infection warrants increased prevention and monitoring efforts. Oxford University Press 2019-12-14 /pmc/articles/PMC6993863/ /pubmed/32025524 http://dx.doi.org/10.1093/ofid/ofz523 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Article
Pereira, Jennifer A
McGeer, Allison
Tomovici, Antigona
Selmani, Alex
Chit, Ayman
The Clinical Burden of Clostridioides difficile in Ontario, Canada
title The Clinical Burden of Clostridioides difficile in Ontario, Canada
title_full The Clinical Burden of Clostridioides difficile in Ontario, Canada
title_fullStr The Clinical Burden of Clostridioides difficile in Ontario, Canada
title_full_unstemmed The Clinical Burden of Clostridioides difficile in Ontario, Canada
title_short The Clinical Burden of Clostridioides difficile in Ontario, Canada
title_sort clinical burden of clostridioides difficile in ontario, canada
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993863/
https://www.ncbi.nlm.nih.gov/pubmed/32025524
http://dx.doi.org/10.1093/ofid/ofz523
work_keys_str_mv AT pereirajennifera theclinicalburdenofclostridioidesdifficileinontariocanada
AT mcgeerallison theclinicalburdenofclostridioidesdifficileinontariocanada
AT tomoviciantigona theclinicalburdenofclostridioidesdifficileinontariocanada
AT selmanialex theclinicalburdenofclostridioidesdifficileinontariocanada
AT chitayman theclinicalburdenofclostridioidesdifficileinontariocanada
AT pereirajennifera clinicalburdenofclostridioidesdifficileinontariocanada
AT mcgeerallison clinicalburdenofclostridioidesdifficileinontariocanada
AT tomoviciantigona clinicalburdenofclostridioidesdifficileinontariocanada
AT selmanialex clinicalburdenofclostridioidesdifficileinontariocanada
AT chitayman clinicalburdenofclostridioidesdifficileinontariocanada